Addison's disease classification: Difference between revisions
Jump to navigation
Jump to search
Aditya Ganti (talk | contribs) |
Aditya Ganti (talk | contribs) |
||
| Line 6: | Line 6: | ||
==Classification== | ==Classification== | ||
===Based on the duration of symptoms=== | ===Based on the duration of symptoms=== | ||
'''Acute adrenal insufficiency''' | '''Acute adrenal insufficiency''' | ||
| Line 20: | Line 20: | ||
'''Secondary adrenal insufficiency''' | '''Secondary adrenal insufficiency''' | ||
*Hypothalamic-pituitary axis suppression | *Hypothalamic-pituitary axis suppression | ||
==References== | ==References== | ||
{{reflist|2}} | {{reflist|2}} | ||
Revision as of 13:38, 17 August 2017
|
Addison's disease Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Addison's disease classification On the Web |
|
American Roentgen Ray Society Images of Addison's disease classification |
|
Risk calculators and risk factors for Addison's disease classification |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] ; Associate Editor(s)-in-Chief: Aditya Ganti M.B.B.S. [2]
Overview
Adrenal insufficiency disorders may be classified into two categories depending on the duration of symptoms and depending on the etiology into acute or chronic forms, and primary or secondary adrenal insufficiency.[1]
Classification
Based on the duration of symptoms
Acute adrenal insufficiency
- Adrenal crisis
Chronic adrenal insufficiency
- Chronic primary adrenal insufficiency
- Chronic secondary adrenal insufficiency
Based on etiology
Primary adrenal insufficiency(Addisons disease)
- Anatomic destruction of the adrenal gland
- Infection (TB)
- Congenital adrenal hyperplasia
Secondary adrenal insufficiency
- Hypothalamic-pituitary axis suppression
References
- ↑ Bornstein SR, Allolio B, Arlt W, Barthel A, Don-Wauchope A, Hammer GD, Husebye ES, Merke DP, Murad MH, Stratakis CA, Torpy DJ (2016). "Diagnosis and Treatment of Primary Adrenal Insufficiency: An Endocrine Society Clinical Practice Guideline". J. Clin. Endocrinol. Metab. 101 (2): 364–89. doi:10.1210/jc.2015-1710. PMC 4880116. PMID 26760044.